載入...
SAT-677 A Case of Opdivo Induced Type 1 Diabetes
BACKGROUND: Opdivo, or Nivolumab is an immunotherapy medication that works as a checkpoint inhibitor. It is used in various cancers not amenable to surgery, including lung cancer and metastatic melanoma. Opdivo has proven to be a beneficial treatment, though it is not without complications including...
Na minha lista:
| 發表在: | J Endocr Soc |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7208640/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.469 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|